Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Indometacin was chosen for a gel to help treat mastopathy and prevent breast cancer.

Tofacitinib taken by mouth helps treat hair loss in children.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

The combination of encorafenib and binimetinib caused few skin issues.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

An arthritis drug helped a person with severe hair loss regrow their hair.